I m a g i o n B i o s y s t e m s L i m i t e d A S X : I B X S e p t e m b e r 2 0 2 6 Molecular MRI: The Next Generation of Imaging B R E A K T H R O U G H F O R E A R L Y C A N C E R D E T E C T I O N F o r w a r d L o o k i n g S t a t e m e n t s This investor presenta tion...
IBX Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Earlier from Imagion Biosystems
- Cleansing Notice
- Application for quotation of securities - IBX
- Notification of cessation of securities - IBX
- IBX Phase 2 Clinical Trial Update
- Change of Director's Interest Notices - RP, BM, NW
Later from Imagion Biosystems
- MagSense Nanoparticle Manufacturing Update
- Imagion Resumes MagSense® Nanoparticle Manufacturing Capabilities
- IBX Secures Central Ethics Approval - Key Phase 2 Milestone
- Appendix 4C and Quarterly Activities Report - September 2026
- Amended Appendix 4C - September 2026
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems